Chennai:Dr.Reddy’s Laboratories decided to buyback around 44, 84,049 of equity shares representing around 2.6 percent for Rs.1,569.4 crore as it has strong cash flows. The maximum...
Hyderabad: Pharma major Dr. Reddy’s Laboratories on Monday announced the signing of a multi-million dollar commercialisation deal with Hatchtech, an Australian pharmaceutical company developing an anti-headlice...
Mumbai: Dr. Reddy’s Laboratories (DRL) Friday said it has completed the acquisition of the brand Habitrol, an over-the-counter nicotine therapy transdermal patch from Novartis Consumer Health....
